Send the following on WhatsApp
Continue to ChatBeiGene 公佈抗體新藥 Tislelizumab 用於治療胃癌全球三期臨床試驗終期結果 https://geneonline.news/beigene-asco-tislelizumab-gastric-cancer/
BeiGene 公佈抗體新藥 Tislelizumab 用於治療胃癌全球三期臨床試驗終期結果 https://geneonline.news/beigene-asco-tislelizumab-gastric-cancer/